Posts Tagged :

Clinical Outcomes

Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacy

This poster evaluates the percent reduction in patient-reported monthly migraine days of patients receiving CGRPs from an integrated health system specialty pharmacy (HSSP).      

Impact of Integrated Health System Specialty Pharmacy Services on Inflammatory Bowel Disease Outcomes 216 115 Shields Health Solutions

Impact of Integrated Health System Specialty Pharmacy Services on Inflammatory Bowel Disease Outcomes

This poster presents an assessment of how health system specialty pharmacy (HSSP) services can improve clinical outcomes for IBD patients.    

Implementation of an Ambulatory Clinical Pharmacist-Led Obesity Care Program Within an Integrated Health-System Specialty Pharmacy 216 115 Shields Health Solutions

Implementation of an Ambulatory Clinical Pharmacist-Led Obesity Care Program Within an Integrated Health-System Specialty Pharmacy

This poster describes the impact of implementing ambulatory clinical pharmacist (ACP)-led medication management services specializing in diabetes care within an integrated HSSP.  

Development and Implementation of Real-Time Dashboards for Specialty Pharmacy Clinical Outcome Measures 216 115 Shields Health Solutions

Development and Implementation of Real-Time Dashboards for Specialty Pharmacy Clinical Outcome Measures

This poster highlights how the implementation of clinical outcome dashboards helps improve quality of care, patient satisfaction, and overall organizational performance and capabilities in health system specialty pharmacies.

Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model 204 115 Shields Health Solutions

Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model

This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
RA Outcomes 2022 216 115 Shields Health Solutions

RA Outcomes 2022

RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.

MS Outcomes 2022 216 115 Shields Health Solutions

MS Outcomes 2022

MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body

Hep-C Outcomes 2022 216 115 Shields Health Solutions

Hep-C Outcomes 2022

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.

HIV Viral Load Suppression in Patients Utilizing an Integrated Health System Specialty Pharmacy Compared to a Non Integrated Specialty Pharmacy Model 216 115 Shields Health Solutions

HIV Viral Load Suppression in Patients Utilizing an Integrated Health System Specialty Pharmacy Compared to a Non Integrated Specialty Pharmacy Model

This poster highlights that among patients evaluated at UMass Memorial HIV Clinic, those filling ARV medications at the HSSP exhibited higher rates of viral suppression in comparison to patients utilizing…